Company intelligence / Profile preview

Neuropractice Consulting Group

Danbury, Connecticut, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Neuropractice Consulting Group is a specialized strategic consultancy serving the biotechnology and pharmaceutical industries with a primary focus on neuroscience. The firm provides expert guidance across the drug development continuum, including clinical trial design, regulatory strategy, and medical affairs. Neuropractice assists clients in navigating the complexities of neurology and psychiatry indications to optimize product value and patient outcomes. Their service offerings encompass medical writing, key opinion leader engagement, and commercial launch support for CNS-targeted therapies.

Therapeutic areas: PsychiatryNeurology
Industry: Consulting

Beyond the preview

Go deeper on Neuropractice Consulting Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuropractice Consulting Group.

Explore the full profile